Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Director/PDMR Shareholding

9 Apr 2014 12:28

RNS Number : 4388E
W.H. Ireland Group PLC
09 April 2014
 



 

WH Ireland Group plc

(the "Company")

Director's Dealings

 

The Company confirms that Richard Killingbeck, CEO of the Company, has today acquired 20,000 ordinary shares at a price 106.5 pence each.

 

Mr Killingbeck now holds the following interests in the share capital of the Company:

 

Number of Shares

Percentage of Voting Rights

Nature of holding

890,000

3.74%

Beneficial*

1,000,000

n/a

Held jointly with the ESOT**

18,292

n/a

SAYE Scheme ***

 

* these shares are held in Mr Killingbeck's SIPP

** these shares are held by the Company's Employee Share Option Trust (ESOT) under a joint ownership arrangement and in which Mr Killingbeck has the ability to exercise under the terms of the ESOT.

*** Under the WH Ireland Save As You Earn Scheme (SAYE), assuming Mr Killingbeck continues to contribute at the full amount defined in his savings contract, this is the maximum number of Ordinary Shares that Mr Killingbeck will have an option to acquire under the terms of the SAYE.

 

For further information please contact:

WH Ireland Group plc

+44 (0) 20 7220 1666

Rupert Lowe, Chairman

www.wh-ireland.co.uk

Richard Killingbeck, CEO

Panmure Gordon (UK) Limited

+44 (0)20 7886 2500

Hugh Morgan (Corporate Finance)

Adam Pollock (Corporate Broking)

MHP Communications

+44(0) 20 3128 8100

Reg Hoare / Jade Neal / Jamie Ricketts

 

whireland@mhpc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFFLSRIAIIS
Date   Source Headline
15th Aug 20232:59 pmRNSResult of General Meeting and Total Voting Rights
31st Jul 20237:25 amRNSPosting of Circular and Notice of General Meeting
28th Jul 20238:53 amRNSResult of Placing
28th Jul 20237:00 amRNSTrading Update & Proposed Placing
22nd Jun 20239:05 amRNSESOT Purchases
15th Jun 20234:57 pmRNSESOT Purchases
24th Apr 20232:11 pmRNSESOT Purchases
21st Apr 20239:20 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSIssue of Equity
3rd Apr 20237:00 amRNSYear End Trading Update
14th Mar 202311:39 amRNSESOT Purchases
9th Feb 20239:10 amRNSESOT Trading
25th Jan 20238:47 amRNSTotal Voting Rights
17th Jan 20238:44 amRNSESOT Purchases
11th Jan 202310:45 amRNSIssue of Equity - Total Voting Rights
20th Dec 20222:08 pmRNSTR-1: Notification of major holdings
16th Dec 202210:19 amRNSRecent appointments across the Group
16th Dec 20227:00 amRNSInterim Results
7th Dec 20227:00 amRNSESOT Purchases
7th Nov 20225:00 pmRNSESOT Trading
4th Nov 20223:45 pmRNSESOT Trading
4th Oct 20228:18 amRNSESOT Purchases
8th Sep 20224:10 pmRNSResult of AGM
8th Sep 20228:23 amRNSESOT Purchases
5th Aug 20227:00 amRNSESOT Purchases
1st Aug 202210:18 amRNSPDMR Shareholding
27th Jul 20227:00 amRNSFinal Results and Notice of AGM
19th Jul 20227:00 amRNSConfirmation of Chairman Appointment
12th Jul 20227:00 amRNSESOT Purchases
20th Jun 20227:00 amRNSESOT Purchases
10th May 20227:00 amRNSNew Debt Capital Markets Business
6th May 20227:37 amRNSESOT Purchases
27th Apr 20224:05 pmRNSIssue of Options
12th Apr 20228:51 amRNSESOT Purchases
31st Mar 20227:00 amRNSBoard Changes
9th Mar 20227:00 amRNSESOT Purchases
17th Feb 202211:23 amRNSPDMR Shareholdings
15th Feb 20227:00 amRNSDirectorate Update
11th Feb 20224:47 pmRNSTR-1: Notification of Major Holdings
11th Feb 20227:00 amRNSTR-1: Notification of Major Holdings
10th Feb 20229:11 amRNSESOT Purchases
7th Feb 202212:39 pmRNSIssue of Equity - Total Voting Rights
24th Jan 20225:12 pmRNSPDMR Shareholdings
18th Jan 20227:00 amRNSPDMR Shareholding
13th Jan 20227:00 amRNSDirectorate Change
6th Jan 20227:00 amRNSESOT Purchases
20th Dec 20217:00 amRNSAppointment of Head of Private Growth Capital
17th Dec 202111:32 amRNSPrivate Capital Team Update
15th Dec 20217:00 amRNSESOT Purchases
7th Dec 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.